Maciaszek J W, Parada N A, Cruikshank W W, Center D M, Kornfeld H, Viglianti G A
The Program in Virology and Immunology, University of Massachusetts Medical Center, Worcester 01605, USA.
J Immunol. 1997 Jan 1;158(1):5-8.
IL-16 is produced by CD8+ lymphocytes and has been reported to inhibit HIV-1 and SIV replication in infected PBMCs. CD4 serves as a receptor for the secreted form of IL-16, and IL-16 binding to CD4 induces signal transduction, which affects the activation state of the cell. We hypothesized, therefore, that the effect of IL-16 on HIV-1 replication might occur at the level of virus expression. In transient transfection studies with HIV-1 LTR-reporter gene constructs we found that pretreatment of CD4+ lymphoid cells with recombinant IL-16 repressed HIV-1 promoter activity up to 60-fold, preventing both PMA and Tat activation. This effect of IL-16 required sequences contained within the core enhancer, but was not simply due to the down-regulation of transcription factors binding to this element.
白细胞介素-16(IL-16)由CD8 +淋巴细胞产生,据报道它能抑制HIV-1和SIV在受感染外周血单核细胞(PBMCs)中的复制。CD4作为分泌型IL-16的受体,IL-16与CD4结合会诱导信号转导,进而影响细胞的激活状态。因此,我们推测IL-16对HIV-1复制的影响可能发生在病毒表达水平。在使用HIV-1长末端重复序列(LTR)-报告基因构建体的瞬时转染研究中,我们发现用重组IL-16预处理CD4 +淋巴细胞可使HIV-1启动子活性降低多达60倍,同时抑制佛波酯(PMA)和反式激活因子(Tat)的激活作用。IL-16的这种作用需要核心增强子内包含的序列,但并非仅仅是由于与该元件结合的转录因子下调所致。